Pharma Journalist -

Amicus Therapeutics announced it is establishing a new Global Research and Gene Therapy Center of Excellence in uCity Square in Philadelphia, PA, to advance its commitment to…
Read More...

AstraZeneca and MSD Inc., Kenilworth, N.J., US (MSD: known as Merck & Co., Inc. inside the US and Canada) announced positive results from the Phase III POLO trial. Results from…
Read More...

Imbrium Therapeutics and TetraGenetics announced a strategic research & development collaboration to utilize TetraGenetics’ antibody discovery technology platform (TetraExpress) in…
Read More...

Selexis SA and Turgut Pharmaceuticals (Turgut Ilaclari A.S.) announced that they have signed two commercial license agreements (CLAs) through which Turgut will leverage Selexis’…
Read More...

SMi reports: Invitations from the conference co-chairs has been released for the upcoming Pain Therapeutics conference in May this year. On the 13th and 14th May 2019 in London, SMi…
Read More...

The 4th annual Pre-filled Syringes West Coast conference and exhibition is returning to San Diego, USA, on June 3rd – 4th 2019. SMi Group are delighted to have Michael Song, Senior…
Read More...

Amgen, Cytokinetics, Incorporated and Servier today announced that METEORIC-HF (Multicenter Exercise Tolerance Evaluation of Omecamtiv Mecarbil Related to Increased Contractility in…
Read More...

Urovant Sciences announced it has entered into a debt financing agreement with Hercules Capital for up to $100 million. Urovant plans to use the proceeds to fund ongoing development of…
Read More...

Ipsen and Clementia Pharmaceuticals announced that they have entered into an agreement for Ipsen to acquire Clementia Pharmaceuticals, including its key late-stage clinical asset…
Read More...

Novartis announced that it is exercising its option to license the rights to develop and commercialize TQJ230, an investigational agent previously known as AKCEA-APO(a)-LRx, from Akcea…
Read More...